CEPI (Coalition for Epidemic Preparedness Innovations)’s Post

Join the PANSOC webinar this week for more knowledge on the politisk effects of epidemics

Thrilled to share insights from our recent presentation for the subject "Complex Case Studies," where we delved into the compelling reasons behind our mission to develop a sustainable inhibitor for combating COVID-19. 🦠🔬 In our pursuit of a safer and healthier world, we discussed why we should target the non-structural protein 12 of the SARS-CoV-2 virus to stop the replication of the virus and prevent the spread of COVID-19. As emerging scientists and future healthcare professionals, this subject and its associated research models hold immense promise in equipping us with the knowledge and tools needed to understand, manage, and effectively combat any potential future pandemics. As always it was a pleasure working with Mahek Thanki, Nisal Keembiyage, and Kevin Narendran Joseph!

Feeling lost in the NIH grant landscape? Let our Essential Guide be your compass.📍Download it at [https://zurl.co/DH0K] to receive a roadmap for K and R applications, making your decisions clearer and more confident.

Drs. Barr, Temkin, Ota Wang and I presented a panel on ORWH at the Academy Health’s Annual Research Meeting (#ARM24) in Baltimore. Each did an excellent job reflecting the breadth and depth of ORWH and The National Institutes of Health research and programming on topics including chronic disease, gender as a social and structural variable, and data science. We shared updates on ORWH research programs, strategic planning and policy efforts, and news about a plethora of other new activities including the White House Initiative on Women’s Health Research with a broad multi-disciplinary audience.  Read more here: bit.ly/46hQwqP

📢 New research is out from our scientists: A roadmap towards risk assessment of microplastics and nanoplastics on early-life health 📚 The proposed roadmap leverages established risk assessment approaches for chemicals, particles, and mixtures   💡 Significant knowledge gaps and complexities related to the distinct properties of micro- and nanoplastics still exist, and we outline which are critical to address.  👩🔬🧑🔬 Cross-disciplinary engagement is required to generate the evidence base necessary for understanding and mitigating risks during early-life from micro- and nanoplastics. Lead author Emily Christopher discusses what this new publication means for the field, next steps, and her own personal journey in public health research. Read the original study ➡️ https://lnkd.in/gKR94dyS  Our short summary ➡️ https://lnkd.in/g3jr9aac   Thanks to Emily and the all the other co-authors for their contributions: Yvette Christopher-de Vries, Anitha Devadoss Ph.D., MRSC, AFHEA, Laurens Mandemaker, Jeske van Boxel, Helena M. Copsey, Hanna Dusza, Juliette Legler, Florian Meirer, Jane Muncke, Tim S. Nawrot, Nelly Saenen, Barbara M. Scholz-Böttcher, Lang Tran, Bert Weckhuysen, Runyu Zou, Lisa Zimmermann, Karen Galea, Roel Vermeulen, and Matthew P Boyles

🔔 Partner Update 🔔 NIH to bolster RECOVER Long COVID research efforts through infusion of $515 million "To bolster Long COVID research efforts, NIH is investing an additional $515 million over the next four years into the Researching COVID to Enhance Recovery (RECOVER) Initiative, a nationwide research program to fully understand, diagnose, and treat Long COVID. Launched in 2021 with $1.15 billion in Congressional appropriations, the RECOVER Initiative is taking a systematic, comprehensive, and rigorous approach to improve our understanding of Long COVID and increase the odds of identifying treatments that work." Read more: https://ow.ly/xw8650QL3zL

You might have heard of the Y combinator. If you are thinking of starting something this might be your first idea. Here is another one to consider. The Pareto fellowship is a vehicle of the Pareto Holdings fund https://pareto20.com that supports early stage founders and academics with technologies that can be converted into startups. You get a small angel investment, guidance and assistance in the licensing of technology from your current institution and guidance in the first steps of building, at the end of your year of fellowship you get access to their network for your fund raising efforts. Application is on rolling basis. #EarlyStageFunding #Startup #AngelInvestment.

With the acute phase of COVID-19 over, at least for the present, it seems a good juncture to reflect on what we have learned so far. What has COVID-19 told us about ourselves and our societies and what has science learned? Find out more in our new Topic Cluster: https://ow.ly/aBzL50PrTA4

"The certainty of a future pandemic requires global cooperation for science and equity. [WHO member states] have an opportunity to lay a solid foundation that supports this ideal" My Editorial out today in Science Magazine, with Anita Cicero https://lnkd.in/eSs7UcPR

Last month, I attended the 2nd annual IRIS conference on global information: Coalized Efforts for Knowledge Transfer of Methods and Technologies, in Lisbon, Portugal. The event was organized by an international coalition of universities that include Harvard T.H. Chan School of Public Health, London School of Hygiene and Tropical Medicine, Sapienza University Rome, Ca’ Foscari University, City University of London, Cambridge University and the Institute for Future Studies in Stockholm with support from the NATO Science for Peace and Security Programme, the UK Cabinet and the Swedish Contingency Agency. To effectively address future infodemics, government agencies engaged in public communication efforts need to develop the capability to use available resources - including social media and population data - to develop the best strategies possible based on the needs of the population they serve, and complexity of the crisis they are facing. I was happy to see that the World Health Organization work on infodemic management help to landscape a whole new area of response in the information ecosystem. What we need now is to invest research into what interventions have worked during the pandemic and how we prepare for the next. https://lnkd.in/etjYj2gk Elena Savoia, Simon Piatek, Anna Hedin Ekström, Andrea Liebman, Fabiana Zollo, Andrea Baronchelli, Jon Roozenbeek, Yara Kyrychenko, Sónia Dias, Maia Mazurkiewicz, LeVoci Vincenzo, Rachael Piltch-Loeb, Christopher Voegeli, Pierluigi Perri, Chad Hartnell, André Peralta-Santos, Carlotta Alfonsi, Zviad Adzinbaia